One-year access to more than 500 world journals available in the system
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
ﻗﯿﻤﺖ
: 300$
- ﻗﯿﻤﺖ ﻭﯾﮋﻩ
: 100$
سفارش
Journals package 1months
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 31 ﺭﻭﺯ
ﻗﯿﻤﺖ
: 100$
- ﻗﯿﻤﺖ ﻭﯾﮋﻩ
: 50$
سفارش
Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial
doi : 10.1016/S1474-4422(25)00426-0
خرید پکیج و مشاهده آنلاین مقاله